[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Kamerling et al., 1989 - Google Patents

Narcotic analgesics, their detection and pain measurement in the horse: a review

Kamerling et al., 1989

View PDF
Document ID
6006383962080087378
Author
Kamerling S
Wood T
DeQuick D
Weckman T
Tai C
Blake J
Tobin T
Publication year
Publication venue
Equine veterinary journal

External Links

Snippet

Narcotic analgesics produce pharmacological effects by interacting with specific opiate receptors. At least five major types of opiate receptors have been recognised. These include μ (morphine) and kappa (ethylketazocine) receptor types. Narcotic analgesics which interact …
Continue reading at thomastobin.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epihephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Kamerling et al. Narcotic analgesics, their detection and pain measurement in the horse: a review
Goldstein et al. Morphine-tolerant longitudinal muscle strip from guinea-pig ileum
Malick et al. Analgesic activity of substance P following intracerebral administration in rats
EP0527975B1 (en) Codeinone derivatives and their pharmaceutical use
US5352680A (en) Delta opioid receptor antagonists to block opioid agonist tolerance and dependence
Popik et al. Pharmacology of ibogaine and ibogaine-related alkaloids
Govitrapong et al. The presence and actions of opioid receptors in bovine pineal gland
Yoburn et al. Upregulation of opioid receptor subtypes correlates with potency changes of morphine and DADLE
JP4359711B2 (en) Drug addiction treatment
EP1063995A1 (en) Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a nmda receptor complex modulator
Aceto et al. Etorphines: μ-opioid receptor-selective antinociception and low physical dependence capacity
Knigge et al. Histaminergic mediation of the stress-induced release of prolactin in male rats
Cone et al. Saliva drug analysis
Calcagnetti et al. [D-Ala2, Leu5, Cys6] enkephalin: Short-term agonist effects and long-term antagonism at delta opioid receptors
WO2005025573A1 (en) Compositions and methods for treating pain
Brent Similar behavioural effects of sigma agonists and PCP-like non-competitive NMDA antagonists in guinea-pigs
Cruz et al. Opioid effects and classification
VonVoigtlander et al. A withdrawal hyperalgesia test for physical dependence: evaluation of μ and mixed-partial opioid agonists
Singh et al. Opioid antagonists. I: Pharmacology and rationale for use in treating self-injury
Helmstetter et al. Ethylketocyclazocine and bremazocine analgesia in neonatal rats
Dewey Narcotic analgesics and antagonist
Bartoletti et al. Cross-sensitization to the excitatory effect of morphine in post-dependent rats
Brent et al. Morphine, D-Pen 2, D-Pen 5 enkephalin and U50, 488H differentially affect the locomotor activity and behaviours induced by quinpirole in guinea-pigs
US20050113401A1 (en) Treatment of chemical dependency with substantially nonaddicting normorphine and norcodeine derivatives
Macia et al. Hypotension induced by growth-hormone-releasing peptide is mediated by mast cell serotonin release in the rat